What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News New VHIR institutional video Introducing the "http://www.youtube.com/user/VHIRtv#p/a/f/0/vlFDQx95k6Y" new video of Vall d'Hebron Research Institute (VHIR). It is a story of who we are, what we want to be and how we want to be seen. Thank you all for your cooperation. "http://www.youtube.com/user/VHIRtv#p/a/f/0/vlFDQx95k6Y" V News VHIR's research shows it's possible to use gene therapy for MNGIE disease Researchers from Vall d'Hebron Research Institute (VHIR) have discovered a possible treatment for patients with the life-threatening minority disease MNGIE. The research group on neuromuscular and mitochondrial diseases, in collaboration with the gene therapy group at VHIR have been able, thanks to News VHIR will collaborate with COMB to support innovative projects of its researchers Vall d'Hebron Institute for Research (VHIR) and the Official College of doctors of Barcelona (COMB) have signed an agreement under which COMB will offer services of technological innovation, analysis and support of entrepreneurial activities to VHIR's researchers. As a result of VHIR intention of be News Dr. Alijotas participates in the program on sterility of '36,5' at BTV Dr. Jaume Alijotas, head of the research in Pregnancy immunopathology at Vall d'Hebron Research Institute (VHIR), participates with his patient during the show '36,5' of BTV, which in its latest edition has been dedicated to infertility. During the program, presented by Dr. Eduard Estivill, there ar News A new generation of drugs improves treatment of hepatitis C Two-thirds of patients with the most common form of hepatitis C can be cured with a new generation of antiviral drugs, as publishes in The New England Journal of Medicine a group of researchers in which appears Dr. Rafael Esteban Mur, member of the liver diseases group at Vall d'Hebron Institute of News Genes identified allow the outpatient diagnosis of endometrial cancer The Biomedical Research and Translational and Pediatric Oncology Unit at Vall d'Hebron Research Institute (VHIR) led by Dr. Jaume Reventós, along with Dr. Antonio Gil-Moreno, from the Gynecology Service of Vall d'Hebron University Hospital and researchers from the biotechnology company Geadic A.I.E. News Dr. Comella defends the economy of knowledge in the KIMconference On March 23 took place at Casa Llotja Mar in Barcelona the KIMconference, entitled "Global Innovation: Challenges & Opportunities', in which participated the director of the Vall de Hebron Research Institute (VHIR), among other experts, to analyze and improve competitiveness in the health sector. De News Diabetics will control their glucose level without pricking several times a day The research group in Diabetes and Metabolism at Vall d'Hebron Research Institute (VHIR), led by Dr. Rafael Simó, is working on a new method to get diabetics can control their blood glucose without pricking several times a day. Diabetes, which affects 10% of the Spanish population, resulting in an e News The Spanish Society of Neurology rewards VHIR's clinical neuroimmunology group Three researchers from the clinical neuroimmunology group at VHIR, led by Dr. Xavier Montalban, have received awards from the Spanish Society of Neurology. Dr. Manuel Comabella has been recognized with Biogen Idec Award for best work on Demyelinating Diseases by “Cerebrospinal fluid chitinase 3-like News VHIR highlights in the presentation of the 13th promotion of the Miguel Servet program On March 15 took place the presentation of the 13th promotion of the Miguel Servet program, that of the 2010 call, at the headquarters of the Instituto de Salud Carlos III (ISCIII) in Madrid. During the ceremony, in addition to the authorities of the ministry, participated Dr. Joan Comella, director News Neurotraumatology and Neurosurgery group at VHIR participates in Brain Awareness Week Research Unit in Neurotraumatology and Neurosurgery at Vall d'Hebron Institut de Recerca (VHIR) participates in Brain Awareness Week organizing the activity 'Live near the problem: learn the causes and speaking with the patient. Traffic accidents and head injuries. Causes and consequences', with lec News El ISCIII financia al VHIR para crear dos redes de investigación El Instituto de Salud Carlos III (ISCIII) ha otorgado al Vall d’Hebron Institut de Recerca (VHIR) la financiación necesaria para crear dos redes de investigación gracias a los fondos FEDER. El VHIR coordinará, por una parte, la Retics de Biobancos (RD09/0076/00066), una red que lidera el Dr. Santiag News VHIR study explains how to block metastasis in childhood rhabdomyosarcoma The Laboratory of Translational Research in pediatric cancer at Vall d'Hebron Research Institute (VHIR) has identified the involvement of a signaling pathway, Notch pathway, in aggressiveness, invasiveness and metastasis of rhabdomyosarcoma, a type of childhood cancer. This discovery will apply a tr News President of EMEA/LatAm Diagnostics visit VHIR A delegation of Roche led by Dr. Michael Heuer, President of EMEA/LatAm Diagnostics, visited on Friday March 11 Vall d'Hebron Institut de Recerca (VHIR) facilities, where met with representatives of management and hepatic diseases research group at VHIR. The meeting, which began with an interview wi News ACE Foundation celebrates 15 years awarding Dr. Chester A. Mathis ACE Foundation, Catalan Institute of Applied Neuroscience, directed by Lluís Tàrraga and Mercè Boada, also leader of the Alzheimer group at Vall d'Hebron Institute of Research (VHIR), celebrated its 15th anniversary with a ceremony in the Auditorium of Barcelona. Dr. Chester A. Mathis, Professor of News Monitoring the PIA should be systematic in the critical Compartment syndrome is defined as an increase in pressure on any closed cavity and causes serious damage. In the case of the abdomen, causes respiratory distress and renal hemodynamics in the patient. The syndrome occurs when intra-abdominal pressure (IAP) increases above 15 mmHg. The elevation of News An apple for Multiple Sclerosis The leader of the Clinical Neuroimmunology group at Vall d'Hebron Institute of Research (VHIR) and director of the Centre for Multiple Sclerosis of Catalonia (CEM-Cat), along with the president of the Multiple Sclerosis Foundation (FEM), Rosamaria Estrany, presented the charity campaign 'An apple fo News UCTS and neuromuscular and mitochondria pathology laboratory appear in 'Redes' The Scientific-Technical Unit Support (UCTS) and the neuromuscular and mitochondria pathology laboratory, led by Dr. Antoni Andreu, of Vall d'Hebron Research Institute (VHIR) serve to illustrate the 86th edition of the TVE show 'Redes', 'Instead of disease, health care'. Eduard Punset interviews thi News VHIR's research facilitates the customization of therapy for hepatitis B and C Vall d'Hebron Research Institute (VHIR) participates in a study that aims to solve the current limitations that impede customizing anti-HBV and anti- HCV (hepatitis B and C) therapies. The project involves the application of ultra pyrosequencing and bioinformatic analysis, along with other technolog News A new treatment improves survival of patients with metastasic breast cancer A clinical research study, led by Dr. Javier Cortes, head of Program BREAST CANCER from Vall d'Hebron University Hospital and VHIO, has shown that eribulin (chemotherapy drug- Halichondria okadai, animal marine sponge) improves the prognosis of patients suffering from metastatic breast cancer. The s Pagination First page « Previous page ‹ … Page 145 Page 146 Current page 147 Page 148 Page 149 … Next page › Last page »
